Funded Tech Companies
Beacon Therapeutics
Beacon Therapeutics, operating out of Alachua, received equity investments from Oxford Science Enterprises, Syncona and Forbion Capital Partners.
Company Overview
Company Name
Beacon Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
14193 NW 119th Terrace, Suite #10
Alachua, FL 32615
USA
Alachua, FL 32615
USA
Phone
Website
Email Address
Company Background Information
Overview
Beacon Therapeutics is an ophthalmic gene therapy company founded to restore and improve the vision of patients with a range of prevalent and rare retinal diseases that result in blindness. Our established scientific foundation combines a late-stage development candidate to treat X-linked retinitis pigmentosa (XLRP) with two innovative and differentiated preclinical programs for prevalent and rare blinding diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/3/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Fellows
Chief Medical Officer
Nadia Waheed
Chief Scientific Officer
Abraham Scaria
Vice President
Eduardo Jacobo
Company Investors
- Oxford Science Enterprises
- Syncona (Elisa Petris)
- Forbion Capital Partners (Dmitrij Hristodorov)
- TCGX
- Advent Life Sciences
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs